We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ablynx Identifies Nanobodies® Achieving Second Milestone in Procter & Gamble Collaboration

News   Jun 28, 2007

 
Ablynx Identifies Nanobodies® Achieving Second Milestone in Procter & Gamble Collaboration
 
 
 

RELATED ARTICLES

A Potential New Treatment for Preventing PTSD

News

A team of researchers has identified a protein complex that is elevated in patients with post-traumatic stress disorder (PTSD). The team have designed a peptide to target and interfere with the complex, this interference could help treat symptoms of the disorder.

READ MORE

Universal Flu Vaccine Protects Against Six Different Influenza Viruses

News

A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine, according to a study by the Institute for Biomedical Sciences at Georgia State University.

READ MORE

Team Builds Drug Compounds That Block Cancer Growth

News

A team has developed new drug compounds that block the "pro-cancer" activity of FOXM1, a transcription factor that regulates the activity of dozens of genes. The compounds suppress tumor growth in both human cells and in mouse models of several types of human breast cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE